KPKaushal Patel

Kaushal Patel

*This is an algorithmically generated author record based on publicly available information.

Kaushal Patel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bachmann's Bundle Versus Right Atrial Appendage Pacing: A Systematic Review and Meta‐Analysis

    by Raam Mannam, Ravi Medarametla, Sunil Bogati, Kaushal Patel, Nirmit Patel, Gaurav Patel, Ashok Runkana, Atul Prakash

    Background: Right atrial appendage (RAA) pacing remains the default atrial lead position despite evidence that non‐physiological atrial activation promotes interatrial dyssynchrony. Bachmann's bundle pacing (BBp) targets the interatrial conduction pathway. We evaluated whether BBp improves electrophysiologic markers of atrial synchrony and whether this is accompanied by a reduction in atrial fibrillation (AF) incidence compared with RAA pacing. Methods: Systematic review and meta‐analysis of studies comparing BBp with RAA pacing. PubMed, Embase, Scopus, Cochrane Library, ClinicalTrials.gov, and reference lists were searched (December 2025). Primary outcome: P‐wave duration change. Secondary: AF incidence. Safety: lead dislodgement. Random‐effects (REML) models. Results: Eight studies comprising 731 patients were analyzed. BBp was associated with a consistent reduction in P‐wave duration (primary analysis, 5 independent‐group studies: MD −34.61 ms; 95% CI −39.84 to −29.38; p < 0.001; I 2 = 0%; 6‐study sensitivity including Vedage et al.: MD −35.24 ms; I 2 = 0%), indicating a shortening of global atrial activation time. BBp was also associated with a lower AF incidence across three RCTs (RR 0.59; 95% CI 0.37–0.94; p = 0.026); however, this estimate was imprecise and sensitive to removal of the dominant contributing trial. Atrial lead dislodgement was rare and events were insufficient for formal pooled analysis; no excess dislodgement signal was observed, but comparative safety remains uncertain given event sparsity. Conclusions: BBp consistently reduced P‐wave duration across diverse paced populations and generated a fragile signal toward lower AF incidence. Comparative lead safety is uncertain due to sparse events. These findings support investigation in prospective trials but do not justify immediate practice change. PROSPERO Registration: CRD420261282981.

  • Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation

    by Atul Prakash, Kaushal Patel, Ajitha Virinchipuram Ganesan, Gaurav Patel, Darshan Gandhi

    Background: Atrial fibrillation (AF) is increasingly conceptualized as a manifestation of atrial cardiomyopathy characterized by progressive fibrosis and structural remodeling. Systemic inflammation may contribute to AF progression and pathogenesis. Elevated inflammatory biomarkers may represent a pro‐inflammatory state, playing a possible role in AF. Left atrial (LA) scar burden serves as a surrogate for atrial fibrosis; however, its association with inflammatory markers is less well established. Objectives: The objectives of the study are as follows: To evaluate a possible association between LA scar burden and inflammatory markers. To identify additional markers correlated with higher scar burden. Methods: We retrospectively analyzed patients undergoing first‐time AF ablation to explore the association between systemic inflammatory markers and LA scar burden. Biomarkers included high‐sensitivity C‐reactive protein (hsCRP), neutrophil‐to‐lymphocyte ratio (NLR), and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP). Demographics, comorbidities, and CHA 2 DS 2 ‐VASc score were recorded. LA scar was quantified during electroanatomic voltage mapping using the BioSense Webster Oct array catheter D1609. Results: A total of 229 patients with AF were included;107 (46.7%) demonstrated significant atrial scar, while 122 (53.3%) did not have significant scar burden. Of these, 147 patients with complete biomarker data were included in the final analysis. Scar‐present patients had significantly higher NT‐proBNP, hsCRP, and BMI, along with a higher prevalence of dyslipidemia, obstructive sleep apnoea, and hypothyroidism, and a significantly different AF type distribution (all p < 0.05). On univariable logistic regression, significant predictors of atrial scar included NT‐proBNP, BMI, hypothyroidism, Longstanding persistent Atrial Fibrillation (AF LS‐persistent), dyslipidemia, obstructive sleep apnea, and CHA 2 DS 2 ‐VASc score, with hsCRP demonstrating a borderline association ( p = 0.076). On multivariable logistic regression, LS‐persistent AF was the only independent predictor of significant atrial scar ( p = 0.026), while BMI and hypothyroidism showed borderline independent associations ( p < 0.10). Conclusions: Our findings suggest a possible correlation of inflammatory markers and Left Atrial scar burden. The association of other comorbidities, like higher BMI, hypothyroidism, dyslipidemia, and sleep apnea, with a higher atrial scar burden may be related to myocardial stress. This suggests an interplay of inflammatory markers and comorbidities, which result in a significant scar burden either directly or indirectly